LACRIMART

Italy

It is used for the disinfection of the ocular mucosa and as a lubricant and humectant for the eye in cases of insufficient tear secretion (Dry Eye Syndrome).

Brand name LACRIMART
Dosage form solution, eye
Active substance / Dosage
Prescription type Over-the-counter
ATC code
Registration number 032159

Frequently asked questions

How should Lacrimart be used?

Instill 1-2 drops into the conjunctival sac 3-4 times a day, keeping the eye open and pressing lightly on the bottle. Do not exceed the recommended doses.

When should this product not be used?

It must not be used in case of hypersensitivity to the components or other chemically related substances. Due to the presence of Benzalkonium Chloride, it should not be used during the application of soft contact lenses, but rather between uses of the lenses themselves.

What are the side effects of Lacrimart?

In some cases, a sensation of burning or irritation (intolerance) may occur, which is generally transient and does not require modification of the treatment. However, prolonged use of topical products can cause sensitization phenomena; in such cases, it is necessary to discontinue treatment and consult a doctor.

Can it be used during pregnancy or breastfeeding?

Yes, Lacrimart can be used during pregnancy and breastfeeding.

Does the drug affect driving or the use of machines?

No, the product does not interfere with the ability to drive or use machines.

How long can the bottle be stored after opening?

The product must not be used more than 30 days after the first opening of the container.

Instructions for use

Lacrimart®
0.01% + 0.15% EYE DROPS
BENZALKONIUM CHLORIDE AND METHYLCELLULOSE
READ ALL INFORMATION CONTAINED IN THE PACKAGE LEAFLET CAREFULLY BEFORE USE. This is a self-medication product
which you can use to treat mild and transient disorders that are easily recognizable and resolvable without
requiring medical assistance.
It can therefore be purchased without a prescription, but must be used correctly to ensure
its effectiveness and minimize potential side effects.

  • For further information and advice, consult your Pharmacist.
  • Consult a Doctor if symptoms do not resolve after a short course of treatment.

Composition
100 ml of solution contains: Active substances: Benzalkonium Chloride 0.01 g, Methylcellulose 0.15 g. Excipients: Sodium Chloride; Potassium Chloride; Edetic Acid (Ethylene Diamine Tetraacetic Acid); water for injections.
Presentation
Lacrimart is an eye drop solution presented in a 10 ml bottle.
What it is
Lacrimart is an ophthalmic disinfectant and lubricant for ocular use.
Marketing Authorization Holder
BAIF International Products New York S.n.c. - Via XX Settembre, 20/68 - Genoa
Manufacturer and Final Controller
Bruschettini S.r.l. - Genoa
Why it is used
Disinfection of the ocular mucosa. Lubricant and moisturizer for the eye in cases of insufficient tear secretion (Dry Eye Syndrome).
When it must not be used
Hypersensitivity to the components or to other substances closely related from a chemical standpoint.
Due to the presence of Benzalkonium Chloride, do not use Lacrimart during the wearing of soft contact lenses, but only between periods of lens wear.
Use during pregnancy and breastfeeding
Lacrimart may be used during pregnancy and breastfeeding.
Which foods or medicines may affect the action of this medicine
If you are using other medicines, consult your Doctor or Pharmacist.
Important information
Lacrimart does not impair the ability to drive or operate machinery.
How to use this medicine
Caution: do not exceed the recommended dosage.
Instill 1–2 drops into the conjunctival sac 3–4 times daily. Keep the eye open and, by gently pressing the body of the bottle, instill one drop into the conjunctival sac. Prolonged use of topical products may lead to sensitization reactions; if this occurs, discontinue treatment and consult a Doctor to establish appropriate therapy.
What to do if you have taken an excessive dose
In case of accidental ingestion of Lacrimart, contact your Doctor immediately.
Undesirable effects
In some cases, intolerance (such as burning or irritation) may occur, although usually transient and without serious consequences, and does not require modification of treatment. Following the instructions in the package leaflet reduces the risk of undesirable effects. These effects are generally transient. If they occur, it is advisable to consult your Doctor or Pharmacist. You should inform your Doctor or Pharmacist of any undesirable effect not described in this leaflet. Request the adverse reaction reporting form available at pharmacies (Model B).
Expiry and storage
The expiry date stated on the label refers to the product kept in its original, unopened packaging and stored correctly. The product must not be used more than 30 days after first opening the container.
Caution: do not use this medicine after the expiry date stated on the packaging.
Keep the medicine out of the reach and sight of children.
It is important to keep both the packaging and the package leaflet for future reference.
Revision of the package leaflet by the Ministry of Health:
December 2005.
BAIF International Products New York S.n.c.
Via XX Settembre, 20–68 - Genoa

Similar drugs

The original data is available in the language of the country of manufacture.

Data source: Italian Medicines Agency (AIFA)

Data last verified: September 21, 2026